The Guardian Australia
·general
·4 hours ago
US states drop Medicaid coverage of GLP-1 weight-loss drugs as demand rises
Multiple US states, including California and South Carolina, have recently cut Medicaid coverage for GLP-1 weight-loss drugs as demand surges. Experts warn this could exacerbate health issues related to obesity, which affects over 40% of US adults. In 2023, Medicaid spending on these drugs reached $71.7 billion, a 500% increase since 2018.
Summary by Glance · The Guardian Australia
Newer
Next
Loving doing this? 🎉
Take it further — get the full app and never miss a moment of what's happening in Australia.
Breaking news alerts
Instant lock-screen notifications the moment big stories break across Australia.
Australian news & events
Politics, sport, weather, local events — all in one swipeable feed, updated around the clock.
Stay ahead of the news cycle
30-second summaries so you're always informed, even on your busiest days.
Loading article…
This publisher's site can't be shown here due to their security settings.
Open full article →No source link available for this article.
✨
Ask AI